The Future of theBrewery Equipment Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theBuccal Drug Delivery System Market?
The increasing incidence of long-term diseases is anticipated to fuel the expansion of the buccal drug delivery systems market. These chronic diseases, lasting a year or more, include conditions like cancer, heart disease, stroke, diabetes, cancer, and arthritis. They are widespread illnesses that can’t be cured, but can be controlled, demanding regular nutrition and medical assistance. Buccal drug delivery systems are apt and efficient for the dispensation of mucosal and transmucosal medications needed by numerous patients suffering from chronic illnesses like diabetes and cancer. For example, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported 41 million deaths, accounting for 74% of total deaths globally due to non-communicable or chronic diseases. The statistics included 17.9 million deaths due to cardiovascular diseases, 9.3 million deaths due to cancer, 4.1 million deaths due to chronic respiratory diseases, and 2.0 million deaths due to diabetes. Hence, the escalating occurrence of chronic health conditions fuels the expansion of the buccal drug delivery systems market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
#What is the Anticipated CAGR of theBuccal Drug Delivery System Market, and What Factors Will Drive It?
In recent times, the market size of the buccal drug delivery system has seen swift expansion. It’s projected to rise from $3.55 billion in 2024 to $3.91 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.3%. Factors contributing to the growth during the historic period include early innovations in drug delivery, take-up by the pharmaceutical industry, clinical research and effectiveness, strategies for market infiltration, and applications specific to certain diseases.
The market size for the buccal drug delivery system is projected to experience rapid expansion in the subsequent few years. The size is anticipated to reach $5.97 billion in 2029, with a compound annual growth rate (CAGR) of 11.1%. Factors contributing to this growth during the forecast period include demands for patient-centric drug delivery, an increasing elderly population, targeted therapies, biologics, and peptide delivery, along with regulatory backing and approvals, and investment in research and development. Key trends during the forecast period comprise patient comfort and adherence, advancements in drug formulation, increase in chronic diseases, pediatric and geriatric attention, as well as improved bioavailability.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8290
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theBuccal Drug Delivery System Market?
Significant enterprises in the buccal drug delivery systems market are concentrating on the creation of novel solutions like oral medications for plaque psoriasis, aiming to boost patient results and optimize the effectiveness of drug delivery. Oral therapies for plaque psoriasis involve utilizing orally taken medications to ease and control the manifestations of plaque psoriasis, a prolonged immune system disorder indicating rapid skin cell growth that results in thick, red, scaly skin patches. To illustrate, Bristol Myers Squibb, an American pharmaceutical company, attained FDA authorization in September 2022 for Sotyktu (deucravacitinib), an oral medication for adults dealing with moderate to severe plaque psoriasis. This marked the first new oral therapy for this issue in almost a decade, introducing an innovative method of action as a selective inhibitor of tyrosine kinase 2 (TYK2).
Who Are the Key Market Players Influencing the Growth of the Corn and Buccal Drug Delivery System Industry?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Which Key Market Segments Comprise the Buccal Drug Delivery System Market and Drive Its Revenue Growth?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smpGlobal Buccal Drug Delivery System Market, Global Buccal Drug Delivery System Market Report, Global Buccal Drug Delivery System Market Trends, Global Buccal Drug Delivery System Market Size
Browse Through More Reports Similar to the Gobal Buccal Drug Delivery System Maret 2025, By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
Injectable Drug Delivery Devices Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
